Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Upstream Bio, Inc. (UPB)
NASDAQ:UPB
Holding UPB?
Track your performance easily
UPB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$10.24 - $29.46
Previous CloseN/A
Volume32.37K
Average Volume (3M)403.32K
Market Cap
$556.87M
Enterprise ValueN/A
Total Cash (Recent Filing)$109.81M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.86
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,596,600
10 Day Avg. Volume292,023
30 Day Avg. Volume403,324
Standard Deviation0.09
R-Squared1.00
Alpha-0.21
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$56.50Price Target Upside413.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Upstream Bio, Inc. News
PremiumCompany Announcements
Upstream Bio Advances Clinical Trials, Strengthens Financials
Options Prices
Currently, No data available
---
Ownership Overview
28.92% Insiders
4.93% Mutual Funds
― Other Institutional Investors
64.38% Public Companies and
Individual Investors
UPB FAQ
What was Upstream Bio, Inc.’s price range in the past 12 months?
Upstream Bio, Inc. lowest stock price was $10.24 and its highest was $29.46 in the past 12 months.
What is Upstream Bio, Inc.’s market cap?
Upstream Bio, Inc.’s market cap is $556.87M.
When is Upstream Bio, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Upstream Bio, Inc.’s earnings last quarter?
Upstream Bio, Inc. released its earnings results on Nov 07, 2024. The company reported -$6.957 earnings per share for the quarter, missing the consensus estimate of -$6.93 by -$0.027.
Is Upstream Bio, Inc. overvalued?
According to Wall Street analysts Upstream Bio, Inc.’s price is currently Undervalued.
Does Upstream Bio, Inc. pay dividends?
Upstream Bio, Inc. does not currently pay dividends.
What is Upstream Bio, Inc.’s EPS estimate?
Upstream Bio, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Upstream Bio, Inc. have?
Upstream Bio, Inc. has 53,596,600 shares outstanding.
What happened to Upstream Bio, Inc.’s price movement after its last earnings report?
Upstream Bio, Inc. reported an EPS of -$6.957 in its last earnings report, missing expectations of -$6.93. Following the earnings report the stock price went up 1.694%.
Which hedge fund is a major shareholder of Upstream Bio, Inc.?
Currently, no hedge funds are holding shares in UPB
---
Upstream Bio, Inc. Stock Smart Score
Company Description
Upstream Bio, Inc.
Upstream Bio is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. We are developing verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin ("TSLP"), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. Preclinical and clinical data to date demonstrate verekitug's highly potent inhibition of the TSLP receptor, which we believe will translate to a differentiated product profile, including improved clinical outcomes, substantially extended dosing intervals and the potential to treat a broad spectrum of patients.
---
UPB Stock 12 Month Forecast
Average Price Target
$56.50
▲(413.64% Upside)
Technical Analysis
Best Analysts Covering UPB
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-30.80%
assigned a buy rating 19 days ago
Copying Yasmeen Rahimi's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -30.80% per trade.
---